세계의 당뇨병성 족궤양 치료제 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Diabetic Foot Ulcer Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

US $ 4,995 ￦ 7,211,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,532,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,265,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

세계의 당뇨병성 족궤양 치료제 시장 규모는 2025년에 75억 7,850만 달러에 달할 것으로 보이며, 2025-2032년의 예측 기간에 5.8%의 CAGR로 확대하며, 2032년에는 112억 4,680만 달러에 달할 것으로 예측됩니다.

당뇨병성 족궤양(DFU) 치료제 시장에는 당뇨병 환자의 만성 상처와 관련된 치유를 촉진하고 합병증을 예방하기 위한 다양한 첨단 치료 및 장비가 포함되며, DFU는 당뇨병의 가장 심각한 합병증 중 하나이며, 효과적인 치료가 이루어지지 않을 경우 감염과 절단으로 이어질 수 있습니다. 이 시장에는 첨단 창상피복재, 피부 대체재, 성장인자, 음압창상치료(NPWT) 기기 등의 솔루션이 포함됩니다. 당뇨병 유병률 증가, 상처 관리에 대한 인식 증가, 기술적으로 진보된 치료제에 대한 수요 증가는 시장 성장을 크게 촉진하고 있습니다.

세계 당뇨병성 족부궤양 치료제 시장은 전 세계 당뇨병 유병률 증가와 당뇨병 환자의 족부궤양 발생률 증가가 주요 요인으로 작용하고 있습니다. 특히 상처 관리에 대한 의료비 지출 증가와 피부 대체재 및 NPWT 장비와 같은 상처 치유 기술의 발전이 시장 확대에 기여하고 있습니다. 또한 당뇨병성 족부궤양의 위험성에 대한 인식이 높아지고 전문 의료 센터의 접근성이 높아지면서 진단 및 치료율이 증가하고 있습니다. 신흥 시장의 유리한 상환 정책 및 증거 기반 치료 프로토콜의 채택 증가도 시장 상승을 지원하고 있습니다.

당뇨병성 족부궤양 치료제 시장은 큰 성장이 예상되지만, 몇 가지 과제에 직면해 있습니다. 특히 중저소득 국가에서는 높은 치료 비용으로 인해 첨단 치료법에 대한 환자들의 접근성이 제한되고 있습니다. 또한 개발도상국에서는 인식 부족과 숙련된 상처 치료 전문가가 부족하여 적시에 진단하고 효과적으로 관리하는 데 어려움을 겪고 있습니다. 혁신적인 상처 치료 제품의 승인과 관련된 규제 장벽으로 인해 신규 진출기업 시장 진입이 늦어지고 있습니다. 또한 환자가 치료 요법을 따르지 않거나, 치료 시기를 놓치면 치료 결과에 악영향을 미칠 수 있습니다.

당뇨병성 족부궤양 치료제 시장은 상처 치료 연구에 대한 투자 증가, 차세대 바이오 인공피부 및 성장인자 개발로 인해 유망한 기회를 가지고 있습니다. 스마트 상처 관리 기기 및 실시간 모니터링을 위한 디지털 건강 플랫폼의 출현은 환자 중심 치료의 새로운 지평을 열었습니다. 아시아태평양, 라틴아메리카, 중동의 미개발 시장은 당뇨병 인구 증가와 의료 인프라의 개선으로 인해 큰 성장 잠재력을 가지고 있습니다. 의료기기 기업과 의료 서비스 프로바이더와의 전략적 제휴와 당뇨병 관리 서비스 강화를 위한 정부의 구상은 시장 기업에게 유리한 길을 열어줄 것입니다.

세계의 당뇨병성 족궤양 치료제 시장에 대해 조사했으며, 제품 유형별, 궤양 유형별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 개요

제2장 시장 개요

• 시장의 범위와 정의
• 시장 역학
• 거시경제 요인
• COVID-19의 영향 분석
• 예측 요인 - 관련성과 영향

제3장 부가가치 인사이트

제4장 가격 분석, 2025년

제5장 세계의 당뇨병성 족궤양 치료제 시장 전망

• 주요 하이라이트
• 시장 규모 분석과 예측
  • 과거 시장 규모(100만 달러) 분석, 2019-2024년
  • 현재 시장 규모(100만 달러) 분석과 예측, 2025-2032년
• 세계의 당뇨병성 족궤양 치료제 시장 전망 : 제품 유형별
  • 서론/주요 조사 결과
  • 과거 시장 규모(100만 달러)와 수량(개) 분석, 제품 유형별, 2019-2024년
  • 현재 시장 규모(100만 달러)와 수량(개) 분석 및 예측, 제품 유형별, 2025-2032년
  • 시장의 매력 분석 : 제품 유형별
• 세계의 당뇨병성 족궤양 치료제 시장 전망 : 궤양 유형별
  • 서론/주요 조사 결과
  • 과거 시장 규모(100만 달러) 분석, 궤양 유형별, 2019-2024년
  • 현재 시장 규모(100만 달러) 분석 및 예측, 궤양 유형별, 2025-2032년
  • 시장의 매력 분석 : 궤양 유형별
• 세계의 당뇨병성 족궤양 치료제 시장 전망 : 최종사용자별
  • 서론/주요 조사 결과
  • 과거 시장 규모(100만 달러) 분석, 최종사용자별, 2019-2024년
  • 현재 시장 규모(100만 달러) 분석 및 예측, 최종사용자별, 2025-2032년
  • 시장의 매력 분석 : 최종사용자별

제6장 세계의 당뇨병성 족궤양 치료제 시장 전망 : 지역별

• 주요 하이라이트
• 과거 시장 규모(100만 달러) 분석, 지역별, 2019-2024년
• 현재 시장 규모(100만 달러) 분석 및 예측, 지역별, 2025-2032년
  • 북미
  • 유럽
  • 동아시아
  • 남아시아와 오세아니아
  • 라틴아메리카
  • 중동 및 아프리카
• 시장의 매력 분석 : 지역별

제7장 북미의 당뇨병성 족궤양 치료제 시장 전망

제8장 유럽의 당뇨병성 족궤양 치료제 시장 전망

제9장 동아시아의 당뇨병성 족궤양 치료제 시장 전망

제10장 남아시아 및 오세아니아의 당뇨병성 족궤양 치료제 시장 전망

제11장 라틴아메리카 당뇨병성 족궤양 치료제 시장 전망

제12장 중동 및 아프리카의 당뇨병성 족궤양 치료제 시장 전망

제13장 경쟁 구도

• 시장 점유율 분석, 2025년
• 시장 구조
• 기업 개요(상세 - 개요, 재무, 전략, 최근 동향)
  • ConvaTec Group Plc
  • B Braun Melsungen AG
  • Acelity LP Inc.
  • Molnlycke Health Care AB
  • 3M Health Care
  • Smith &Nephew Plc.
  • Coloplast Corp.
  • Medline Industries, LP
  • Medtronic Plc

제14장 부록

KSA

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global Diabetic Foot Ulcer Therapeutics Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Diabetic Foot Ulcer Therapeutics Market Size (2025E): US$ 7,578.5 Mn
• Projected Market Value (2032F): US$ 11,246.8 Mn
• Global Market Growth Rate (CAGR 2025 to 2032): 5.8%

Diabetic Foot Ulcer Therapeutics Market - Report Scope:

The diabetic foot ulcer (DFU) therapeutics market encompasses a range of advanced treatments and devices aimed at promoting healing and preventing complications associated with chronic wounds in diabetic patients. DFUs are among the most severe complications of diabetes, often leading to infections and amputations if not treated effectively. The market includes solutions such as advanced wound dressings, skin substitutes, growth factors, and negative pressure wound therapy (NPWT) devices. Rising diabetes prevalence, increased awareness of wound care, and growing demand for technologically advanced therapeutics are significantly propelling market growth.

Market Growth Drivers:

The global diabetic foot ulcer therapeutics market is primarily driven by the growing global prevalence of diabetes and the rising incidence of foot ulcers among diabetic populations. Increased healthcare spending, particularly in wound care management, along with advancements in wound healing technologies such as skin substitutes and NPWT devices, are contributing to market expansion. Moreover, heightened awareness regarding the risks of untreated diabetic foot ulcers and the growing availability of specialized care centers have led to increased diagnosis and treatment rates. Favorable reimbursement policies in developed regions and the increasing adoption of evidence-based treatment protocols also support the market's upward trajectory.

Market Restraints:

Despite strong growth prospects, the diabetic foot ulcer therapeutics market faces several challenges. High treatment costs, especially in low- and middle-income countries, limit patient access to advanced therapies. In addition, lack of awareness in underdeveloped regions and the shortage of trained wound care specialists hinder timely diagnosis and effective management. Regulatory hurdles related to the approval of innovative wound care products can slow market entry for new players. Furthermore, patient non-compliance with treatment regimens and delayed medical attention can negatively impact therapeutic outcomes.

Market Opportunities:

The diabetic foot ulcer therapeutics market holds promising opportunities driven by increasing investments in wound care research and the development of next-generation bioengineered skin substitutes and growth factors. The emergence of smart wound care devices and digital health platforms for real-time monitoring opens new frontiers for patient-centric care. Untapped markets in Asia-Pacific, Latin America, and the Middle East present considerable growth potential due to the rising diabetic population and improving healthcare infrastructure. Strategic collaborations between medical device companies and healthcare providers, as well as government initiatives to enhance diabetic care services, further create lucrative avenues for market players.

Key Questions Answered in the Report:

• What are the primary factors driving the global diabetic foot ulcer therapeutics market's growth?
• Which regions and product segments are experiencing the highest demand for DFU treatment?
• How are innovations in wound healing technologies influencing market dynamics?
• Who are the key players in the diabetic foot ulcer therapeutics market, and what strategies are they adopting to stay competitive?
• What are the emerging trends and future projections for the global DFU therapeutics market?

Competitive Intelligence and Business Strategy:

Leading companies in the global diabetic foot ulcer therapeutics market, such as ConvaTec Group Plc, B Braun Melsungen AG, and Smith & Nephew Plc, are investing heavily in product development, clinical trials, and strategic partnerships to expand their therapeutic portfolios. These companies focus on improving treatment efficacy, patient comfort, and wound healing time through advanced materials and biologics. Market leaders are also strengthening distribution channels and entering emerging economies to boost market penetration. Emphasis on personalized wound care solutions, along with regulatory approvals for new therapies, continues to shape the competitive landscape.

Companies Covered in This Report:

• ConvaTec Group Plc
• B Braun Melsungen AG
• Acelity L.P. Inc.
• Molnlycke Health Care AB
• 3M Health Care
• Smith & Nephew Plc.
• Coloplast Corp.
• Medline Industries, LP
• Medtronic Plc

Market Segmentation

By Product Type:

• Advanced Wound Dressings
• Skin Substitutes
• Negative Pressure Wound Therapy Devices
• Growth Factors

By Ulcer Type:

• Neuropathic Ulcers
• Ischemic Ulcers
• Neuro-Ischemic Ulcers

By End-user:

• Hospitals
• Specialty Clinics
• Long-term Care Centers
• Ambulatory Surgical Centers

By Region:

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Diabetic Foot Ulcer Therapeutics Market Snapshot, 2025-2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Type Adoption Analysis
• 3.2. Regulatory Landscape
• 3.3. Value Chain Analysis
• 3.4. PESTLE Analysis
• 3.5. Porter's Five Force Analysis

4. Price Analysis, 2025A

• 4.1. Key Highlights
• 4.2. Key Factors Impacting Product Type Prices
• 4.3. Pricing Analysis, By Product Type
• 4.4. Regional Prices and Product Type Preferences

5. Global Diabetic Foot Ulcer Therapeutics Market Outlook

• 5.1. Key Highlights
  • 5.1.1. Market Volume (Units) Projections
  • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
  • 5.1.3. Absolute $ Opportunity
• 5.2. Market Size (US$ Mn) Analysis and Forecast
  • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  • 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
• 5.3. Global Diabetic Foot Ulcer Therapeutics Market Outlook: Product Type
  • 5.3.1. Introduction / Key Findings
  • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product Type, 2019-2024
  • 5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
    • 5.3.3.1. Advanced Wound Dressings
    • 5.3.3.2. Skin Substitutes
    • 5.3.3.3. Negative Pressure Wound Therapy Devices
    • 5.3.3.4. Growth Factors
  • 5.3.4. Market Attractiveness Analysis: Product Type
• 5.4. Global Diabetic Foot Ulcer Therapeutics Market Outlook: Ulcer Type
  • 5.4.1. Introduction / Key Findings
  • 5.4.2. Historical Market Size (US$ Mn) Analysis, By Ulcer Type, 2019-2024
  • 5.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Ulcer Type, 2025-2032
    • 5.4.3.1. Neuropathic Ulcers
    • 5.4.3.2. Ischemic Ulcers
    • 5.4.3.3. Neuro-Ischemic Ulcers
  • 5.4.4. Market Attractiveness Analysis: Ulcer Type
• 5.5. Global Diabetic Foot Ulcer Therapeutics Market Outlook: End User
  • 5.5.1. Introduction / Key Findings
  • 5.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
  • 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 5.5.3.1. Hospitals
    • 5.5.3.2. Specialty Clinics
    • 5.5.3.3. Long-term Care Centers
    • 5.5.3.4. Ambulatory Surgical Centers
  • 5.5.4. Market Attractiveness Analysis: End User

6. Global Diabetic Foot Ulcer Therapeutics Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
• 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia and Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Diabetic Foot Ulcer Therapeutics Market Outlook

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Product Type
  • 7.2.3. By Ulcer Type
  • 7.2.4. By End User
• 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
  • 7.4.1. Advanced Wound Dressings
  • 7.4.2. Skin Substitutes
  • 7.4.3. Negative Pressure Wound Therapy Devices
  • 7.4.4. Growth Factors
• 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Ulcer Type, 2025-2032
  • 7.5.1. Neuropathic Ulcers
  • 7.5.2. Ischemic Ulcers
  • 7.5.3. Neuro-Ischemic Ulcers
• 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 7.6.1. Hospitals
  • 7.6.2. Specialty Clinics
  • 7.6.3. Long-term Care Centers
  • 7.6.4. Ambulatory Surgical Centers
• 7.7. Market Attractiveness Analysis

8. Europe Diabetic Foot Ulcer Therapeutics Market Outlook

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Product Type
  • 8.2.3. By Ulcer Type
  • 8.2.4. By End User
• 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Turkey
  • 8.3.8. Rest of Europe
• 8.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
  • 8.4.1. Advanced Wound Dressings
  • 8.4.2. Skin Substitutes
  • 8.4.3. Negative Pressure Wound Therapy Devices
  • 8.4.4. Growth Factors
• 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Ulcer Type, 2025-2032
  • 8.5.1. Neuropathic Ulcers
  • 8.5.2. Ischemic Ulcers
  • 8.5.3. Neuro-Ischemic Ulcers
• 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 8.6.1. Hospitals
  • 8.6.2. Specialty Clinics
  • 8.6.3. Long-term Care Centers
  • 8.6.4. Ambulatory Surgical Centers
• 8.7. Market Attractiveness Analysis

9. East Asia Diabetic Foot Ulcer Therapeutics Market Outlook

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Product Type
  • 9.2.3. By Ulcer Type
  • 9.2.4. By End User
• 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
  • 9.4.1. Advanced Wound Dressings
  • 9.4.2. Skin Substitutes
  • 9.4.3. Negative Pressure Wound Therapy Devices
  • 9.4.4. Growth Factors
• 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Ulcer Type, 2025-2032
  • 9.5.1. Neuropathic Ulcers
  • 9.5.2. Ischemic Ulcers
  • 9.5.3. Neuro-Ischemic Ulcers
• 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 9.6.1. Hospitals
  • 9.6.2. Specialty Clinics
  • 9.6.3. Long-term Care Centers
  • 9.6.4. Ambulatory Surgical Centers
• 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Diabetic Foot Ulcer Therapeutics Market Outlook

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Product Type
  • 10.2.3. By Ulcer Type
  • 10.2.4. By End User
• 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of South Asia & Oceania
• 10.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
  • 10.4.1. Advanced Wound Dressings
  • 10.4.2. Skin Substitutes
  • 10.4.3. Negative Pressure Wound Therapy Devices
  • 10.4.4. Growth Factors
• 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Ulcer Type, 2025-2032
  • 10.5.1. Neuropathic Ulcers
  • 10.5.2. Ischemic Ulcers
  • 10.5.3. Neuro-Ischemic Ulcers
• 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 10.6.1. Hospitals
  • 10.6.2. Specialty Clinics
  • 10.6.3. Long-term Care Centers
  • 10.6.4. Ambulatory Surgical Centers
• 10.7. Market Attractiveness Analysis

11. Latin America Diabetic Foot Ulcer Therapeutics Market Outlook

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Product Type
  • 11.2.3. By Ulcer Type
  • 11.2.4. By End User
• 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of Latin America
• 11.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
  • 11.4.1. Advanced Wound Dressings
  • 11.4.2. Skin Substitutes
  • 11.4.3. Negative Pressure Wound Therapy Devices
  • 11.4.4. Growth Factors
• 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Ulcer Type, 2025-2032
  • 11.5.1. Neuropathic Ulcers
  • 11.5.2. Ischemic Ulcers
  • 11.5.3. Neuro-Ischemic Ulcers
• 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 11.6.1. Hospitals
  • 11.6.2. Specialty Clinics
  • 11.6.3. Long-term Care Centers
  • 11.6.4. Ambulatory Surgical Centers
• 11.7. Market Attractiveness Analysis

12. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Outlook

• 12.1. Key Highlights
• 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 12.2.1. By Country
  • 12.2.2. By Product Type
  • 12.2.3. By Ulcer Type
  • 12.2.4. By End User
• 12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 12.3.1. GCC Countries
  • 12.3.2. Egypt
  • 12.3.3. South Africa
  • 12.3.4. Northern Africa
  • 12.3.5. Rest of Middle East & Africa
• 12.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
  • 12.4.1. Advanced Wound Dressings
  • 12.4.2. Skin Substitutes
  • 12.4.3. Negative Pressure Wound Therapy Devices
  • 12.4.4. Growth Factors
• 12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Ulcer Type, 2025-2032
  • 12.5.1. Neuropathic Ulcers
  • 12.5.2. Ischemic Ulcers
  • 12.5.3. Neuro-Ischemic Ulcers
• 12.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 12.6.1. Hospitals
  • 12.6.2. Specialty Clinics
  • 12.6.3. Long-term Care Centers
  • 12.6.4. Ambulatory Surgical Centers
• 12.7. Market Attractiveness Analysis

13. Competition Landscape

• 13.1. Market Share Analysis, 2025
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping By Market
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 13.3.1. ConvaTec Group Plc
    • 13.3.1.1. Overview
    • 13.3.1.2. Segments and Product Types
    • 13.3.1.3. Key Financials
    • 13.3.1.4. Market Developments
    • 13.3.1.5. Market Strategy
  • 13.3.2. B Braun Melsungen AG
  • 13.3.3. Acelity L.P. Inc.
  • 13.3.4. Molnlycke Health Care AB
  • 13.3.5. 3M Health Care
  • 13.3.6. Smith & Nephew Plc.
  • 13.3.7. Coloplast Corp.
  • 13.3.8. Medline Industries, LP
  • 13.3.9. Medtronic Plc

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations

관련자료